Comments

Omega Therapeutics

OMGANASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.84
-0.09-4.66%
At Close: -
$1.83
-0.01-0.54%
After Hours: 7:37 PM EDT
15 minutes delayed
Omega Therapeutics (OMGA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$30.00
Lowest Price Target1
$4.00
Consensus Price Target1
$12.13

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Omega Therapeutics (NASDAQ:OMGA) Stock, Analyst Ratings, Price Targets, Forecasts

Omega Therapeutics Inc has a consensus price target of $12.13 based on the ratings of 8 analysts. The high is $30 issued by Jefferies on August 24, 2021. The low is $4 issued by Goldman Sachs on May 24, 2022. The 3 most-recent analyst ratings were released by Raymond James, HC Wainwright & Co., and Chardan Capital on June 18, 2024, May 13, 2024, and May 7, 2024, respectively. With an average price target of $10.33 between Raymond James, HC Wainwright & Co., and Chardan Capital, there's an implied 464.66% upside for Omega Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Raymond James
HC Wainwright & Co.
Chardan Capital
Piper Sandler
Wedbush

1calculated from analyst ratings

Analyst Ratings for Omega Therapeutics

Buy NowGet Alert
06/18/2024Buy Now555.74%Raymond James
Ryan Deschner
 → $12Initiates → OutperformGet Alert
05/13/2024Buy Now555.74%HC Wainwright & Co.
Robert Burns
 → $12ReiteratesBuy → BuyGet Alert
05/07/2024Buy Now282.51%Chardan Capital
Keay Nakae
$7 → $7MaintainsBuyGet Alert
04/30/2024Buy Now555.74%HC Wainwright & Co.
Robert Burns
 → $12ReiteratesBuy → BuyGet Alert
04/03/2024Buy Now391.8%Piper Sandler
Edward Tenthoff
$10 → $9ReiteratesOverweight → OverweightGet Alert
04/01/2024Buy Now282.51%Chardan Capital
Keay Nakae
$12 → $7MaintainsBuyGet Alert
01/04/2024Buy Now555.74%Wedbush
Robert Driscoll
 → $12ReiteratesOutperform → OutperformGet Alert
11/13/2023Buy Now555.74%HC Wainwright & Co.
Robert Burns
$11 → $12MaintainsBuyGet Alert
11/10/2023Buy Now555.74%Wedbush
Robert Driscoll
$19 → $12MaintainsOutperformGet Alert
09/01/2023Buy Now501.09%HC Wainwright & Co.
Robert Burns
 → $11ReiteratesBuy → BuyGet Alert
08/04/2023Buy Now555.74%Chardan Capital
Keay Nakae
 → $12ReiteratesBuy → BuyGet Alert
06/06/2023Buy Now501.09%HC Wainwright & Co.
Robert Burns
 → $11ReiteratesBuy → BuyGet Alert
05/08/2023Buy Now555.74%Chardan Capital
Keay Nakae
 → $12Reiterates → BuyGet Alert
03/31/2023Buy Now501.09%HC Wainwright & Co.
Robert Burns
 → $11Reiterates → BuyGet Alert
03/24/2023Buy Now501.09%HC Wainwright & Co.
Robert Burns
 → $11Reiterates → BuyGet Alert
03/10/2023Buy Now501.09%JonesTrading
Catherine Novack
 → $11Initiates → BuyGet Alert
03/03/2023Buy Now446.45%Piper Sandler
Edward Tenthoff
$8 → $10MaintainsOverweightGet Alert
12/08/2022Buy Now501.09%HC Wainwright & Co.
Robert Burns
 → $11Initiates → BuyGet Alert
09/23/2022Buy Now555.74%Chardan Capital
Keay Nakae
 → $12Initiates → BuyGet Alert
05/24/2022Buy Now118.58%Goldman Sachs
Salveen Richter
$7 → $4MaintainsNeutralGet Alert
05/23/2022Buy Now282.51%Piper Sandler
Edward Tenthoff
$30 → $7MaintainsOverweightGet Alert
08/24/2021Buy Now1867.21%Wedbush
Robert Driscoll
—Initiates → OutperformGet Alert
08/24/2021Buy Now1539.34%Jefferies
Chris Howerton
—Initiates → BuyGet Alert
08/24/2021Buy Now1539.34%Piper Sandler
Edward Tenthoff
—Initiates → OverweightGet Alert
08/24/2021Buy Now1102.19%Goldman Sachs
Salveen Richter
—Initiates → NeutralGet Alert

FAQ

Q

What is the target price for Omega Therapeutics (OMGA) stock?

A

The latest price target for Omega Therapeutics (NASDAQ:OMGA) was reported by Raymond James on June 18, 2024. The analyst firm set a price target for $12.00 expecting OMGA to rise to within 12 months (a possible 555.74% upside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Omega Therapeutics (OMGA)?

A

The latest analyst rating for Omega Therapeutics (NASDAQ:OMGA) was provided by Raymond James, and Omega Therapeutics initiated their outperform rating.

Q

When was the last upgrade for Omega Therapeutics (OMGA)?

A

There is no last upgrade for Omega Therapeutics

Q

When was the last downgrade for Omega Therapeutics (OMGA)?

A

There is no last downgrade for Omega Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Omega Therapeutics (OMGA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Therapeutics was filed on June 18, 2024 so you should expect the next rating to be made available sometime around June 18, 2025.

Q

Is the Analyst Rating Omega Therapeutics (OMGA) correct?

A

While ratings are subjective and will change, the latest Omega Therapeutics (OMGA) rating was a initiated with a price target of $0.00 to $12.00. The current price Omega Therapeutics (OMGA) is trading at is $1.83, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch